Fondazione Italiana Sindromi Mielodisplastiche

Fondazione Italiana Sindromi Mielodisplastiche (FISiM) is a prominent Italian non-profit research foundation dedicated to advancing the study and treatment of myelodysplastic syndromes (MDS) and related hematological malignancies. The foundation coordinates a nationwide network of clinical centers, facilitating multicenter clinical trials and maintaining a comprehensive national patient registry to improve epidemiological understanding and clinical outcomes. FISiM's research focus includes the optimization of hypomethylating agents, the evaluation of novel targeted therapies, and the refinement of prognostic scoring systems. By bridging academic research with clinical practice, the foundation plays a pivotal role in establishing national diagnostic and therapeutic guidelines in Italy. Their work is essential for fostering innovation and improving the quality of life for patients suffering from myeloid neoplasms.